Financial Tearsheet

Company Overview

Tenax Therapeutics Inc (NASDAQ:TENX)

Tenax Therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients who require treatment for various critical care conditions. 

Recent Financial News

Stock Performance

Today's Open 4.92
Volume 915
Day Range 4.82 - 4.92
52 Week Range 4.41 - 12.63
Bid/Ask 4.65 / 4.96
Bid/Ask Size 100 X 1,600
Previous Close 4.85
Market Cap 137.79 million
Shares Outstanding 28.12 million
Dividend/Yield 0.00 / 0.00%
EPS (TTM) 0.530103
P/E Ratio (TTM) 9.24

Recent XBRL Filings

Filing Date Form Type Description View
Aug 14, 2018 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
May 15, 2018 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Apr 02, 2018 10-K Annual report htmlhtml   pdfpdf   xbrlxbrl  
Nov 09, 2017 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Aug 09, 2017 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  

Management Team

Michael B. Jebsen, Interim CEO, Chief Financial Officer

Douglas Hay, PhD, EVP of Regulatory Affairs

Nancy Hecox, EVP, Legal Affairs, General Counsel, and Corporate Secretary

Doug Randall, EVP of Commercial and Business Operations

Board of Directors

Dr. Ronald Blanck, Chairman

John Kelley, Chief Executive Officer

Anthony DiTonno, Director

James Mitchum, Director

Gregory Pepin, Director

Gerald Proehl, Director

Chris A. Rallis, Director